COVID-19 / Coronavirus
AGBA Group Holding Limited (NASDAQ: 'AGBA') Announces Share Repurchase Program
HONG KONG, April 18, 2023 /PRNewswire/ -- NASDAQ-listed, AGBA Group Holding Limited ("AGBA"), the leading one- stop financial supermarket inHong Kong, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to 1,000,000 ordinary shares of ...
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023
FY2023 Revenues Increased by Approximately 30% Year Over Year GAITHERSBURG, Md., April 18, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new ...
World Hemophilia Day 2023 - "Access for All: Prevention of bleeds as the global standard of care"
MONTREAL, April 17, 2023 /PRNewswire/ -- April 17, 2023 is World Hemophilia Day. The theme of the event this year is "Access for All: Prevention of bleeds as the global standard of care". Building on last year's theme, the call to action for the community in 2023 is to come together and advocate ...
Caring Pharmacy partners with Appier to deliver a personalized multi-channel experience for Malaysians
TAIPEI, April 13, 2023 /PRNewswire/ -- Appier
NCCN Annual Conference Brings Up Important Questions for Improving Cancer Care
National Comprehensive Cancer Network's yearly conference for interdisciplinary healthcare providers focused on applying the latest evidence-based recommendations and fostering welcoming environments for patients and staff that lead to better treatment, outcomes, and quality-of-life for people wi...
China's First Nectin-4 Targeted ADC 9MW2821 Clinical Progress Released
SHANGHAI, April 6, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the whole industry chain layout, announced its Nectin-4 targeted site-specific ADC asset (R&D code: 9MW2821) demonstrated promising clinical data. The preliminary data show positive therapeut...
AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering
NEW YORK, April 6, 2023 /PRNewswire/-- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platfo...
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio
CAMBRIDGE, Mass., April 5, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and provider of integrated solutions from "Idea to IND" (I to I™ ), announced today it has entered into a collaboration agreement wi...
NASDAQ-listed wealth and health firm, AGBA Group Holding Limited to acquire Sony Life Financial Advisers Pte Ltd in Singapore
* AGBA Group signs agreement today to acquire Sony Life Financial Advisers Pte Ltd inSingapore * Acquisition is a key milestone for AGBA's business and expansion beyond the Greater Bay Area intoSoutheast Asia HONG KONG and SINGAPORE, April 5, 2023 /PRNewswire/ -- NASDAQ-listed AGBA Group Hold...
Standigm and Institut Pasteur Korea Identify Lead Compounds for Resistant Tuberculosis Thanks to Right Foundation Grant
Research achievements enabled by a combination of advanced AI platforms,
research capabilities, and drug discovery technologies
SEOUL, South Korea, April 4, 2023 /PRNewswire/ -- Standigm
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.
NEW YORK, April 3, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform foc...
The World's Second Approved Biosimilars of Denosumab (MAILISHU)
SHANGHAI, April 3, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for injection (trade name: MAILISHU, project code: 9MW0311), which is developed by its wholly-owned subsidiary T-m...
Fosun International Holds 2022 Annual Results Announcement. Guo Guangchang: Realizing Sustainable and Rapid Development in 2023
HONG KONG, March 31, 2023 /PRNewswire/ -- "Despite how difficult in 2022, the past is behind us. We should focus on 2023 and the future. Despite how much hardship entrepreneurs have endured, we never dwell on the past. We are always thinking ahead and advancing." On the morning of 30 March, Fosu...
Yunkang Group Announces First Annual Results Since Listing
Revenue increases by 121.4% to RMB 3,756 million Profit attributable to owners of the Company of RMB 377 million Three major businesses grow rapidly through in-depth service and lean management HONG KONG, March 31, 2023 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Cod...
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2022
SHANGHAI, March 31, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines, today announced its financial results for the full year...
Kintor Pharma Announces 2022 Annual Results and Recent Business Progress
SUZHOU, China, March 30, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended31 Decembe...
Viva Biotech Announced 2022 Annual Results:
Revenue and Gross Profit with Steady Growth Competitive Advantages of One-stop Platform Continuously Demonstrating Financial highlights of the year ended December 31, 2022: * Revenue amounted to RMB2,379.6 million, representing a year-on-year (YoY) increase of 13.1% * Gross profit amounted to...
Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform
SHANGHAI, March 30, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with cancer and other major diseases, today announced the launch of "E-Class," medical education intelligent content p...
Great Place To Work unveils Best Workplaces in the Inaugural Singapore Healthcare and Biopharma List 2023
Employees express trust in leaders' competence and integrity and value fairness and impartiality as part of the workplace culture SINGAPORE, March 30, 2023 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture announced the 10 companies who are Best WorkplacesTM in its ...
Broncus Medical (02216.HK) Announces Annual Results for 2022
Product sales in China for 2022 increased 50% compared to the same period in 2021, while product development and commercialization are steadily advancing. HANGZHOU, China, March 30, 2023 /PRNewswire/ -- On March 29, 2023, Broncus Medical (02216.HK), a leader in precise interventional diagnosis an...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 317 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 287 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Most Read
/C O R R E C T I O N -- Addverb/
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
Multiple achievements made in China-Hungary BRI conference
